YmAbs is a clinical-stage biopharmaceutical company developing novel antibody therapeutics for oncology targets.
Business Model:
Revenue: $40M
Employees: 51-200
Address: 230 Park Avenue
City: New York
State: NY
Zip: 10169
Country: US
YmAbs is a clinical-stage biopharmaceutical company developing novel antibody therapeutics for oncology targets.
Contact Phone:
+12128479841
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
9/20/2018
Ticker Symbol:
YMAB
IPO Price:
$16/share
Amount Raised:
$96M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 2/2021 | Post-IPO Equity | $115M | 9/2018 | IPO | $96M |
|
11/2017 | Private Equity Round | $0 |
Sofinnova Investments HBM Healthcare Investments AG Scopia Capital Scopia Capital Sofinnova Investments Sofinnova Investments HBM Healthcare Investments AG Scopia Capital Scopia Capital Sofinnova Investments |
10/2017 | Private Equity Round | 1 | $50M |
HBM Healthcare Investments AG HBM Healthcare Investments AG HBM Healthcare Investments AG HBM Healthcare Investments AG |
10/2019 | Post-IPO Equity | $143.8M | 11/2017 | Private Equity Round | 3 | $30M |
Sofinnova Investments HBM Healthcare Investments AG Scopia Capital Scopia Capital Sofinnova Investments Sofinnova Investments HBM Healthcare Investments AG Scopia Capital Scopia Capital Sofinnova Investments |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|